Treatment for NSTEMI?

Treatment for NSTEMI?

• A. MONA
• B. Reperfusion therapy for immediate restoration of blood flow
• C. Lifestyle changes only
• D. Surgical revascularization only

Answer: (A)

In NSTEMI the priority is to stabilize the patient quickly, relieve chest pain, and begin measures that prevent further clot formation while planning definitive treatment. The MONA approach reflects these immediate actions: Morphine for pain relief if chest pain persists, Oxygen if the patient is hypoxemic, Nitrates to dilate coronary vessels and improve oxygen supply to the heart, and Aspirin to inhibit platelet aggregation right away. Aspirin is especially important because it helps prevent growth of the clot that’s already reducing blood flow. Reperfusion via immediate restoration of blood flow is the hallmark of STEMI care because there is a complete occlusion that needs rapid opening. In NSTEMI, the blockage is usually partial and patients are usually stabilized first and then assessed for an early invasive strategy (angiography and possible PCI) within a risk-guided timeframe. So simply choosing immediate reperfusion as the sole treatment isn’t appropriate for NSTEMI. Lifestyle changes and delays in definitive revascularization don’t address the acute event. While long-term management includes risk reduction and possible surgical options, they’re not the sole or immediate treatment for the acute NSTEMI episode. MONA represents the essential first steps to relieve symptoms and begin antithrombotic therapy, setting the stage for further interventions.

In NSTEMI the priority is to stabilize the patient quickly, relieve chest pain, and begin measures that prevent further clot formation while planning definitive treatment. The MONA approach reflects these immediate actions: Morphine for pain relief if chest pain persists, Oxygen if the patient is hypoxemic, Nitrates to dilate coronary vessels and improve oxygen supply to the heart, and Aspirin to inhibit platelet aggregation right away. Aspirin is especially important because it helps prevent growth of the clot that’s already reducing blood flow.

Reperfusion via immediate restoration of blood flow is the hallmark of STEMI care because there is a complete occlusion that needs rapid opening. In NSTEMI, the blockage is usually partial and patients are usually stabilized first and then assessed for an early invasive strategy (angiography and possible PCI) within a risk-guided timeframe. So simply choosing immediate reperfusion as the sole treatment isn’t appropriate for NSTEMI.

Lifestyle changes and delays in definitive revascularization don’t address the acute event. While long-term management includes risk reduction and possible surgical options, they’re not the sole or immediate treatment for the acute NSTEMI episode. MONA represents the essential first steps to relieve symptoms and begin antithrombotic therapy, setting the stage for further interventions.